Lumeda Inc.

Lumeda Inc.

生物技术研究

Rocky Hill,Connecticut 360 位关注者

Improving Adjuvant Therapy For Lung Cancer

关于我们

Lumeda Inc. is a medical technology company advancing photodynamic therapy (PDT) as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies. Lumeda’s breakthrough light dosimetry product called DigiLum? is designed to activate a photosensitizer drug and deliver PDT to reduce the recurrence of cancer and enhance antitumor immunity. DigiLum? applies advanced photonics and proprietary Artificial Intelligence (AI) software to enable thoracic surgeons to control dosimetry, reduce treatment time and capture data for future treatment planning.

网站
https://lumedainc.com/
所属行业
生物技术研究
规模
2-10 人
总部
Rocky Hill,Connecticut
类型
私人持股
创立
2020

地点

  • 主要

    101 Hammer Mill Rd

    US,Connecticut,Rocky Hill,06067

    获取路线

Lumeda Inc.员工

动态

相似主页

查看职位

融资

Lumeda Inc. 共 3 轮

上一轮

A 轮

US$4,300,000.00

Crunchbase 上查看更多信息